Virtu Financial’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$255K Buy
+5,077
New +$287K 0.01% 856
2026
Q2
– Sell
-33,323
Closed -$1.85M – 1567
2026
Q1
$1.85M Buy
+33,323
New +$1.79M 0.08% 169
2025
Q4
– Sell
-15,531
Closed -$476K – 1624
2025
Q3
$476K Buy
+15,531
New +$356K 0.03% 581
2024
Q2
– Sell
-9,850
Closed -$222K – 1271
2024
Q1
$222K Buy
+9,850
New +$233K 0.02% 742
2018
Q1
– Sell
-2,923
Closed -$294K – 1913
2017
Q4
$294K Sell
2,923
-5,584
-66% -$411K 0.02% 1288
2017
Q3
$297K Buy
+8,507
New +$229K 0.01% 1392

Other funds holding ANAB

Virtu Financial's ANAB Position: Q3 2026 in Review

Virtu Financial opened a new position in AnaptysBio (ANAB) in Q3 2026: 5,077 shares worth $255K. The stake represents 0.01% of the portfolio and ranks #856 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ANAB as recently as Q1 2026.

Virtu Financial first reported a position in ANAB in Q3 2017 and has held it in 6 quarters since. The position peaked at $1.85M in Q1 2026. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

  • Virtu Financial held 5,077 shares of AnaptysBio worth $255K as of Q3 2026.
  • AnaptysBio was a new Virtu Financial position in Q3 2026.
  • AnaptysBio made up 0.01% of Virtu Financial's portfolio in Q3 2026, its #856 holding.
  • Virtu Financial first reported a position in AnaptysBio in Q3 2017 and has held it in 6 quarters since.
  • Virtu Financial's AnaptysBio position peaked at $1.85M in Q1 2026.
  • 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.